GE Healthcare is continuing its partnership with Endra Life Sciences to develop Endra's Thermo Acoustic Enhanced Ultrasound (TAEUS) system.
The firms first announced their joint venture in 2016; it has now been extended to January 2020.
Under the terms of the agreement, GE Healthcare will continue to support Endra's efforts to complete commercialization of its TAEUS technology for use in fatty liver applications by providing equipment and technical advice and facilitating introductions to GE Healthcare clinical ultrasound customers. In return, Endra will afford GE Healthcare certain rights of first offer with respect to manufacturing and licensing for the target application.
Endra expects a commercial launch in the second half of this year.
